Mekhanizmy boli pri khronicheskom pankreatite: chto i komu naznachit' praktikuyushchemu vrachu?


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Chronic pancreatitis (CP) is a common disease with potentially severe course and a high risk of development of serious complications: pancreatogenic diabetes, trophological failure, pancreatic cancer. Only a timely diagnosis and adequate treatment of patients with CP allows to reduce the risk of serious complications and poor outcomes. Abdominal pain syndrome in CP is an early and most significant manifestation. The correct interpretation of complaints of CP patients, purposeful examination and treatment are the basis for the improvement of quality of life and increase in life expectancy. In most cases, for the relief of pancreatic pain in the absence of indications for endoscopic and surgical treatment, it is necessary to use a combined drug therapy, including non-narcotic analgesics, myotropic antispasmodics (hyoscine butylbromide), pancreatin preparations with a high content of proteases, and inhibitors of gastric secretion.

全文:

受限制的访问

参考

  1. Егоров В.И., Кучерявый Ю.А., Петров Р.В., Ванькович А.Н. Обзор международных рекомендаций по подходам к хирургическому лечению хронического панкреатита: взгляд терапевта и хирурга // Экспер. и клин. гастроэнтерол. 2013. № 4. С. 54-65.
  2. Ивашкин В.Т., Маев И.В., Шифрин О.С. и др. Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению хронического панкреатита (проект) // Росс. журн. гастроэнтерол., гепатол., и колопроктол. 2013. № 1. С. 66-87.
  3. Кузин М.И., Данилов М.В., Благовидов Д.Ф. Хронический панкреатит. М., 1985. 368 с.
  4. Кучерявый Ю.А. Хирургическое и эндоскопическое лечение хронического панкреатита с позиций гастроэнтеролога: кому, когда, как? // Доказат. гастроэнтерол. 2013. № 1. С. 13-21.
  5. Кучерявый Ю.А., Москалева А.Б., Устинова Н.Н. Патофизиология боли и подходы к лечению при хроническом панкреатите // Врач 2011. № 10. С. 46-50.
  6. Кучерявый Ю.А, Оганесян Т.С. Аутоиммунный панкреатит: алгоритмы диагностики и подходы к лечению // Клин. перспект. гастроэнтерол., гепатол. 2010. № 6. С. 3-10.
  7. Маев И.В., Кучерявый Ю.А. Болезни поджелудочной железы. В 2 томах. М., 2008. 976 с.
  8. Allescher HD, Neuhaus H, Hagenmuller F, Clas-sen M. Effect of N-butylscopolamine on sphincter of Oddi motility in patients during routine ERCP - a manometric study. Endoscopy 1990;22(4):160-63.
  9. Ammann RW, Muench R, Otto R, et al. Evolution and regression of pancreatic calcification in chronic pancreatitis: a prospective long-term study of 107 patients. Gastroenterology 1988;95:1018-28.
  10. Ammann RW, Muellhaupt B. The natural history of pain in alcoholic chronic pancreatitis. Gastroenterology 1999;116:1132-40.
  11. Ammann RW. Diagnosis and management of chronic pancreatitis: current knowledge. Swiss Med Wkly 2006;136(12):166-74.
  12. Bhardwaj P, Garg PK, Maulik SK, et al. A randomized controlled trial of antioxidant supplementation for pain relief in patients with chronic pancreatitis. Gastroenterology 2009; 136(1):149-59.
  13. Bhasin DK, Rana SS, Sidhu RS, et al. Clinical presentation and outcome of endoscopic therapy in patients with symptomatic chronic pancreatitis associated with pancreas divisum. JOP 2013;14(1):50-6.
  14. Bornman PC, Botha JF, Ramos JM, et al. Guideline for the diagnosis and treatment of chronic pancreatitis. S Afr Med J 2010;100(12 Pt 2):845-60.
  15. Burton F, Alkaade S, Collins D, et al. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States. Aliment Pharmacol Ther 2011;33(1):149-59.
  16. Cavallini G, Frulloni L, Pederzoli P, et al. Longterm follow-up of patients suffering from chronic pancreatitis in Italy. Scand J Gastroentrol 1998;33:880-89.
  17. Ceppa EP, Pitt HA, Hunter JL, et al. Hereditary pancreatitis: endoscopic and surgical management. J Gastrointest Surg 2013;17(5):847-57.
  18. Ceyhan GO, Demir IE, Maak M, Friess H. Fate of nerves in chronic pancreatitis: Neural remodeling and pancreatic neuropathy. Best Pract Res Clin Gastroenterol 2010;24:311-22.
  19. Chen F, Chen J, Dong JH, et al. The feasibility and reliability of using circular electrode for sphincter of Oddi electromyography in anaesthetised rabbits. Neurogastroenterol Motil 2009;21(6):651-56.
  20. Delhaye M, Arvanitakis M, Verset G, et al. Longterm clinical outcome after endoscopic pancreatic ductal drainage for patients with painful chronic pancreatitis. Clin Gastroenterol Hepatol 2004;2:1096-106.
  21. Deshpande V, Gupta R, Sainani N, et al. Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance. Am J Surg Pathol 2011;35(1):26-35.
  22. Dimcevski G, Sami SA, Funch-Jensen P, et al. Pain in chronic pancreatitis: the role of reorganisation in the central nervous system. Gastroenterology 2007;132:1546-56.
  23. Ford AC, Talley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008;337:2313.
  24. Friess H, Shrikhande S, Shrikhande M, et al. Neural alterations in surgical stage chronic pancreatitis are independent of the underlying aetiology. Gut 2002;50(5):682-86.
  25. Frulloni L, Falconi M, Gabbrielli A, et al. Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 2010;42(6):381-406.
  26. Hall TC, Dennison AR, Garcea G. The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review. Langenbecks Arch Surg 2012;397(6):889-98.
  27. He SQ, Yao JR, Zhang FX, et al. Inflammation and nerve injury induce expression of pancreatitis-associated protein-II in primary sensory neurons. Mol Pain 2010; 26:6-23.
  28. Kaczor R, Nowak A, Nowakowska-Dulawa E, Rybicka J. Manometric evaluation of the effects of intravenous administration of glucagon, buscopan and papaverine on the contractile activity of the sphincter of Oddi. Pol Arch Med Wewn 1992;87(2):96-103.
  29. Kloppel G. Pathology of chronic pancreatitis and pancreatic pain. Acta Chir Scand 1990;156:261-65.
  30. Ma ZH, Ma QY, Sha HC, Wu SL, Wen J. Magnetic resonance cholangiopancreatography for the detection of pancreatic duct stones in patients with chronic pancreatitis. World J Gastroenterol 2009;15(20):2543-46.
  31. Malfertheiner P, Mayer D, Buchler M, et al. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 1995;36(3):450-54.
  32. Martinez J, Abad-Gonzalez A, Aparicio JR, et al. The Spanish Pancreatic Club recommendations for the diagnosis and treatment of chronic pancreatitis: Part 1 (diagnosis). Pancreatology 2013;13:8-17.
  33. Maydeo A, Soehendra N, Reddy N, Bhandari S. Endotherapy for chronic pancreatitis with intra-canalar stones. Endoscopy 2007;39:653-58.
  34. Michalski CW, Gorbachevski A, Erkan M, et al. Mononuclear cells modulate the activity of pancreatic stellate cells which in turn promote fibrosis and inflammation in chronic pancreatitis. J Transl Med 2007;5:63.
  35. Mueller-Lissner S, Tytgat GN, Paulo LG, et al. Placebo- and paracetamol-controlled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. Aliment Pharmacol Ther 2006;23(12):1741-48.
  36. Muller-Lissner S, Schafer E, Kondla A. Symptoms and their interpretation in patients self-treating abdominal cramping and pain with a spasmolytic (Butylscopolamine Bromide) A pharmacy-based survey. Pharmacol Pharm 2011; 2:82-7 full text: http://www.SciRP.org/journal/pp).
  37. Pezzilli R, Morselli-Labate AM. Alcoholic pancreatitis: pathogenesis, incidence and treatment with special reference to the associated pain. Int J Environ Res Public Health 2009;6(11): 2763-82.
  38. Ramesh H, Reddy N, Bhatia S, et al. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 entericcoated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology 2013;13:133-39.
  39. Song TJ, Kim JH, Kim MH, et al. Comparison of clinical findings between histologically confirmed type 1 and type 2 autoimmune pancreatitis. J Gastroenterol Hepatol 2012;27(4):700-08.
  40. Steer ML, Waxman I, Freedman S. Chronic pancreatitis. N Engl J Med 1995;332:482-90.
  41. Takenaga H, Magaribuchi T, Nakajima H. Effects of timepidium bromide, hyoscine-N-butyl-bromide and atropine on the isolated guinea pig gallbladder and sphincter of Oddi. Jpn J Pharmacol 1980;30(3):317-23.
  42. Toskes PP, Forsmark CE, DeMeo MT, et al. A multicenter controlled trial of octreotide for the pain of chronic pancreatitis. Pancreas 1993;8(6):774.
  43. Tringali A, Boskoski I, Costamagna G. The role of endoscopy in the therapy of chronic pancreatitis. Best Pract Res Clin Gastroenterol 2008:22(1):145-65.
  44. Tytgat GN. Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin 2008;24(11):3159-73.
  45. Wu SD, Kong J, Wang W, et al. Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry. Hepatobiliary Pancreat Dis Int 2003;2(1):121-25.
  46. Xu GY, Winston JH, Shenoy M, et al. Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis. Gastroenterology 2007;133:1282-92.
  47. Zhu Y, Colak T, Shenoy M, et al. Transforming growth factor beta induces sensory neuronal hyperexcitability, and contributes to pancreatic pain and hyperalgesia in rats with chronic pancreatitis. Mol Pain 2012;8:65.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2013
##common.cookie##